Low-oxygen training before surgery for lung squamous cell cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether special training that exposes you to lower oxygen levels before surgery can help treat early-stage squamous cell lung cancer. The goal is to see if this approach improves outcomes when combined with surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 years old
- Diagnosed with stage II or IIIA squamous cell lung cancer (not other lung cancer types)
- Your doctor believes the tumor can be completely removed by surgery
- Good overall health and ability to do daily activities with minimal limitations
- Normal or near-normal blood counts, liver, and kidney function
- No previous cancer treatments (chemotherapy, radiation, immunotherapy, or surgery for this cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pre-surgery exercise program can improve your fitness and recovery. If you have advanced non-small cell lung cancer and are scheduled for treatment with chemotherapy and/or immunotherapy before surgery, this study might help you prepare physically.
This trial tests if doing exercise before lung cancer surgery can help people with moderate-to-high risk. Participants will exercise for a short period to see if it improves their recovery.
This trial tests whether doing exercise training before lung cancer surgery can help you recover better. It is for people with low fitness levels who live with another adult at home.
This trial tests a combination of radiation therapy, an immunotherapy drug called toripalimab, and chemotherapy given before surgery for stage II-III non-small cell lung cancer. The goal is to shrink the tumor before removal and improve survival outcomes.
This study tests whether adding a structured exercise program before surgery affects the immune environment of your lung tumor. It may help strengthen your immune system and improve treatment response.
This trial tests whether giving low-dose focused radiation and two immunotherapy drugs before lung surgery can improve outcomes for people with operable, resectable non-small cell lung cancer. It aims to shrink or control the cancer before surgery and help reduce the chance it comes back.
Hear when a new Lung Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.